Clinical Trial Update: Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating two-month regimens with novel drug combinations to improve effectiveness against drug-sensitive pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Pulmonary

Snippet

Sponsor: University College, London | Conditions: Tuberculosis, Pulmonary | Phase 2, Phase 3 | Status: COMPLETED